Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.

AIDS research and human retroviruses - 1 Sept 2015

Guardiola Montse, Echeverria Patricia, González Marta, Vallvé Joan C, Puig Jordi, Clotet Bonaventura, Ribalta Josep, Negredo Eugènia

Abstract excerpt

HIV-infected patients treated with highly active antiretroviral therapy (HAART) may be predisposed to a lipid profile, associated with increased cardiovascular risk, derived from having high triglycerides (TG) and low high-density lipoprotein cholesterol (HDLc) levels. We propose that genetic variability leaves some HIV-infected patients more predisposed to this lipid profile than others. We performed a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol Ester Transfer Proteins

Share to Cross-Sectional Studies

Share to Dyslipidemias

Share to HIV Infections

Share to Lipase

Share to Lipoprotein Lipase

Source

Identifiers

PMID: 26101956
DOI: 10.1089/AID.2015.0061

Genes

CETP
LPL
APOA5
APOC3
APOE
LRP5
VLDLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.PMID 26101956Read ↗

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.Semantic proximity Read ↗

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Semantic proximity Read ↗

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.Semantic proximity Read ↗

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.Semantic proximity Read ↗

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Semantic proximity Read ↗

Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.Semantic proximity Read ↗

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.Semantic proximity Read ↗

Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.Semantic proximity Read ↗

Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients in a Ghanaian populationSemantic proximity Read ↗

Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.Semantic proximity Read ↗

Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.Semantic proximity Read ↗

Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.